Revolution: A Deep Dive Into the Mechanism of Action and Clinical Impact of SGLT2 and GLP1 Agents

Author(s): Lori Dugan Brien, DNP, ACNP-BC; Abbye Rae Solis, DNP, ACNP-BC; Catherine Tierney, DNP, RN, ACNP-BC

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 1.00

Expires Dec 31, 2028

Topics: Pharmacology

Population: Adult

Role: APRN, Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Before you Begin

1. Reflect on the following question: What new knowledge or perspective do you hope to gain from this activity?

2. Review: Implicit Bias and its Impact on Patient Outcomes (License requirement for California)

Description

The benefits of SGLT2 inhibitors and GLP-1 receptor agonists, beyond their original purpose of glucose control, have some referring to these agents as wonder drugs. Evidence shows their benefit to patients with heart failure, chronic kidney disease, obesity and cardiovascular disease. APRNs must be aware of individuals who may benefit from being prescribed an SGLT2 inhibitor or a GLP-1 receptor agonist. This session describes the indications for and the pharmacology of SGLT2 inhibitors and GLP-1 receptor agonists. Case studies illustrate the benefits and risks associated with prescribing these medications. Pharmacology content = 100%

Objectives

  • Identify the mechanism of action, metabolism, dosing, side effects and cost of select SGLT2 inhibitors and GLP-1 receptor agonists.
  • Explain the cardiovascular, metabolic and renal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.
  • Describe the risks associated with SGLT2 and GLP-1 inhibitor therapies.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.